The role of chemotherapy in newly diagnosed ependymoma of childhood

Pediatric Neurosurgery

Volumn 28, Issue 5, 1998, Pages 273-278

  Souweidane, Mark M ^a,d   Bouffet, Eric ^b   Finlay, Jonathan ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^c NEW YORK UNIVERSITY   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chemotherapy; Ependymoma; Second look surgery

Indexed keywords

AZIRIDINYLBENZOQUINONE; CARBOPLATIN; CHLORMETHINE; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; METHOTREXATE; NITROSOUREA; PREDNISONE; PROCARBAZINE; TENIPOSIDE; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; DRUG EFFICACY; DRUG INDICATION; DRUG SENSITIVITY; EPENDYMOMA; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RECURRENT CANCER; SECOND LOOK SURGERY;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; EPENDYMOMA; HUMANS; INFANT; NEOPLASM RECURRENCE, LOCAL;

EID: 0031658092     PISSN: 10162291     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028664     Document Type: Article

References (63)

1. Pierre-Kahn A, Hirsch JF, Roux FX, Renier D, Sainte-Rose C: Intracranial ependymomas in childhood - Survival and functional results of 47 cases. Childs Brain 1983;10:145-156.
2. Tomita T, McLone DG, Das L, Brand WN: Benign ependymomas of the posterior fossa in childhood. Pediatr Neurosci 1986;14:277-285.
3. Nazar GB, Hoffman HJ, Becker LE, Jenkin DK, Humphreys RP: Infratentorial ependymomas in childhood: Prognostic factors and treatment. J Neurosurg 1990;72:408-417.
4. Foreman NK, Love S, Thorne R: Intracranial ependymomas: Analysis of prognostic factors in a population-based series. Pediatr Neurosurg 1996;24:119-125.
5. Pollack IF, Gerszten PC, Martinez AJ, Lo KH, Shultz B, Albright AL, Janosky J, Deutsch M: Intracranial ependymomas of childhood: Long-term outcome and prognostic factors. Neurosurgery 1995;37:655-667.
6. Perilongo G, Massimino M, Sotti G, Belfontali T, Masiero L, Rigobello L, Garre L, Carli M, Lombardi F, Solero C, Sainati L, Canale V, Brach del Prever A, Giangaspero F, Andreussi L, Massa C, Madon E: Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neurooncology Group. Med Pediatr Oncol 1997;29:79-85.
7. Rousseau P, Habrand JL, Sarrazin D, Kalifa C, Terrier-Lacombe MJ, Rekacewicz C, Rev A: Treatment of intracranial ependymomas of children: Review of a 15-year experience. J Radiat Oncol Biol Phys 1994;28:381-386.
8. Mork SJ, Rubinstein LJ: Ependymoblastoma. A reappraisal of a rare embryonal tumor. Cancer 1977;40:907-915.
9. Khan AB, D'Souza BJ, Wharam MD, Champion LAA, Sinks LF, Woo SY, McCullough DC, Leventhal BG: Cisplatin therapy in recurrent childhood brain tumors. Cancer Treat Rep 1982;66:2013-2020.
10. Sexauer CL, Khan AB, Burger PC, Krischer JP, van Eys J, Vats T, Ragab AH: Cisplatin in recurrent pediatric brain tumors. A POG phase II study: A Pediatric Oncology Group study. Cancer 1985;56:1497-1501.
11. Walker RW, Allen JC: Treatment of recurrent primary intracranial childhood tumors with cis-diamminedichloroplatinum. Ann Neurol 1983;14-371-372.
12. Bertolone SJ, Baum ES, Krivit W, Hammond D: Phase II trial of cis-platinum diammmodichloride (CDDP) in recurrent childhood brain tumors; a CCSG trial. Proc Am Soc Clin Oncol 1983;2:72.
13. Gaynon PS, Ettinger LJ, Moel D, Siegel SE, Baum ES, Krivit W, Hammond GD: Pediatric phase I trial of carboplatin: A Children's Cancer Study Group report. Cancer Treat Rep 1987;71:1039-1042.
14. Gaynon PS, Ettinger LS, Baum ES, Seigel SE, Krailo M, Hammond GD: Carboplatin in childhood brain tumors: A Children's Cancer Study Group phase II trial. Cancer 1990;66:2465-2469.
15. Wilson CB, Cutin P, Baldrey EB, Crafts D, Levin VA, Enot KJ: Single-agent chemotherapy of brain tumors. Arch Neurol 1976;33:739-744.
16. Rosenblum ML, Reynolds AF, Smith KA, Rumack BH, Walker MD: Chloroethylcyclohexyl-nitrosourea (CCNU) in the treatment of malignant brain tumors. J Neurosurg 1973;39:306-314.
17. Sklansky BD, Mann-Kaplan RS, Reynolds AF Jr, Rosenblum ML, Walker MD: 4′-Dimethyl-epipodophylotoxin-β-D-thenylidene-glucoside (PTG) in the treatment of malignant intracranial neoplasms. Cancer 1974;33:460-467.
18. Levin VA: Chemotherapy of primary brain tumors. Neurol Clin 1985;3:855-866.
19. Wilson CB, Norrell HA: Brain tumor chemotherapy with intrathecal methotrexate. Cancer 1969;23:1038-1045.
20. Djerassi I, Kim JS, Shulman K: High-dose methotrexate-citrovorum factor rescue in the management of brain gliomas. Cancer Treat Rep 1977;61:691-694.
21. Ettinger LJ, Krailo M, Krivit W, Ruccione K, Hammond D: Phase II study of AZQ in childhood brain tumors. Proc Am Soc Clin Oncol 1985;4:238.
22. Chastagner P, Olive-Sommelet D, Kalifa C, Brunat M, Zucker JM, Baranzelli MC, Tron P: Phase II trial of ifosfamide in recurrent childhood brain tumors. J Med Pediatr Oncol 1989;17:335.
23. Seiler RW: Combination chemotherapy with VM-26 and CCNU in primary malignant brain tumors in children. Helv Pediatr Acta 1980;35:51-56.
24. Cangir A, Ragab AH, Steuber P, Land VJ, Berry DH, Krischer JP: Combination chemotherapy with vincristine, procarbazine, prednisone with or without nitrogen mustard (MOPP vs. OPP) in children with recurrent brain tumors. Med Pediatr Oncol 1984;12:1-3.
25. Miser J, Krailo M, Smithson W, Belasco J, Ortega J, Hammond D: Treatment of children with recurrent brain tumors with ifosfamide (ifos), etoposide (VP-16), and mesna (M): Results of a phase II trial. Proc Am Soc Clin Oncol 1983;8:2001-2006.
26. Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME, Sanford RA, Mulhern RK, James HE, Freeman CR, Kun L: Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 1993;328:1725-1731.
27. Duffner PK, Cohen ME, Kun L, Krischer JP, Sanford RA, Burger PC, Horowitz ME, Friedman HS: Prognostic factors in infants with ependymomas. Ann Neurol 1995;38:546.
28. Kalifa C, Raquin MA, Bouffet E, Doz F, Chastagner P, Perel Y, Demaille MC, Monpoux F: Chemotherapy without irradiation (RT) in ependymoma in patients younger than four. J Neurooncol 1997;33:268.
29. Greenberg ML, Weitzman S, Chan H, Solh H, Jenkin DK, Doherty M, Huffman HJ, Feltis A: Combination chemotherapy (CMT) using ifosfamide, etoposide (VP-16). and carboplatinum in pediatric brain tumors. Med Pediatr Oncol 1991;19:406.
30. Geyer JR, Zeltzer PM, Boyett JM, Rorke LB, Stanley P, Albright AL, Wisoff JH, Milstein JM, Allen JC, Finlay JL, Avers GD, Shruin SB, Stevens KR, Bleyer WA: Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: A report from the Children's Cancer Group. J Clin Oncol 1994;12:1607-1615.
31. Evans AE, Andersen JR, Lefkowitz-Boudreaux IB, Finlay JL: Adjuvant chemotherapy of childhood posterior fossa ependymoma: Cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: A Children's Cancer Group study. Med Pediatr Oncol 1996;27:8-14.
32. Needle MM, Goldwein JW, Grass J, Cnaan A, Bergman I, Molloy P, Sutton L, Zhao H, Garvin JH Jr, Phillips PC: Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood. Cancer 1997;80:341-347.
33. Robertson PL, Zeltzer PM, Boyett JM, Rorke LB, Allen JC, Geyer JR, Stanley P, Li H, Albright AL, McGuire-Cullen P, Finlay JL, Stevens KR, Milstein JM, Packer RJ, Wisoff JH: Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: A report of the Children's Cancer Study Group. J Neurosurg 1998;88:695-703.
34. Mason WP, Goldman S, Grovas A, Finlay JL: Intensive chemotherapy and autologous bone marrow reconstitution for children with new or recurrent ependymoma. Proc Am Soc Clin Oncol 1995;14:145.
35. Grill J, Kalifa C, Doz F: A high-dose busulfanthiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase II study. Pediatr Neurosurg 1996;25:7-12.
36. Mahoney DH Jr, Strother D, Camilla B, Bowen T, Ghim T, Pick T, Wall D, Yu L, Shuster JJ, Friedman HS: High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: A pilot Pediatric Oncology Group study. J Clin Oncol 1996;14:382-388.
37. Graham ML, Herndon JE II, Casey JR, Chaffee S, Cioci GH, Krischer JP, Kurtzberg J, Laughlin MF, Longee DC, Olson JF, Paleologus N, Pennington CN, Friedman HS: High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors. J Clin Oncol 1997;15:1814-1823.
38. Kannuki S, Bando K, Shirakawa N, Matsumoto K, Takaue T, Kuroda Y: Intensive and high-dose chemotherapy with peripheral blood stem cell transfusion for pediatric malignant brain tumors. Neurol Surg 1995;23:411-415.
39. Mason WP, Grovas A, Halpern S, Dunkel IJ, Garvin J, Heller G, Rosenblum ML, Gardner S, Lyden D, Sands S, Puccetti D, Lindsley K, Merchant TE, O'Malley B, Bayer L, Petriccione M, Allen JC, Finlay JL: Intensive chemotherapy and bone marrow rescue for young children with newly-diagnosed malignant brain tumors. J Clin Oncol 1998;16:1-12.
40. Foreman NK, Love S, Gill SS, Coakham HB: Second-look surgery for incompletely resected fourth ventricle ependymomas: Technical case report. Neurosurgery 1997;40:856-860.
41. Wollner N, Wachtel AE, Exelby PR, Centore D: Improved prognosis in children with intra-abdominal non-Hodgkin's lymphoma following LSA2L2 protocol chemotherapy. Cancer 1980;45:3034-3039.
42. Marina NM, Rao E, Etcubanas E, Jenkins JJ, Kun LE, Thompson EI: The role of second-look surgery in the management of advanced germ cell malignancies. Cancer 1991;68:309-315.
43. Schroder R, Ploner C, Ernestus R-I: The growth potential of ependymomas with varying grades of malignancy measured by the Ki-67 labeling index and mitotic index. Neurosurg Rev 1993;16:145-150.
44. Ausman JI, Shapiro WR, Rall DP: Studies on the chemotherapy of experimental brain tumors: Development of an experimental model. Cancer Res 1970;30:2394-2400.
45. Horowitz ME, Parham DM, Douglass EC, Kun LE, Houghton JA, Houghton PJ: Development and characterization of human ependymoma xenograft HxBr5. Cancer Res 1987;47:499-504.
46. Aaron RH, Elion GB, Colvin OM, Graham M, Keir S, Bigner DD, Friedman HS: Busulfan therapy of central nervous system xenografts in athymic mice. Cancer Chemother Pharmacol 1994;35:127-131.
47. Friedman HS, Dolan ME, Pegg AE, Marcelli SL, Keir S, Catino JJ, Bigner DD, Schold SC Jr: Activity of temozolomide in the treatment of central nervous system xenografts. Cancer Res 1995;55-2853-2857.
48. Hare CB, Elion GB, Houghton PJ, Houghton JA, Keir S, Marcelli SL, Bigner DD, Friedman HS: Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)carbonyloixy-camptothecin against pediatric and adult central nervous system tumor xenografts. Cancer Chemother Pharmacol 1997;39:187-191.
49. Shouten-van Meeteren AYN, Pieters R, Huismans DR, Ouwerkerk WJR, Tan WF, Veerman AJP: In vitro drug resistance of childhood brain tumors for cisplatin and etoposide. Med Pediatr Oncol 1995;25:258.
50. Chou PM, Barquin N, Gonzalez-Crussi F, Sanz CR, Tomita T, Reyes-Mugica M: Ependymomas in children express the multidrug resistance gene: Immunohistochemical and molecular biologic study. Pediatr Pathol Lab Med 1996;16:551-561.
51. Geddes JF, Vowles GH, Ashmore SM, Cockburn HA, Darling JL: Detection of multidrug resistance gene product (P-glycoprotein) expression in ependymomas. Neuropathol Appl Neurobiol 1994;20:118-121.
52. Lee SM, Thatcher N, Margison GP: Alkylguanine-DNA alkyltransferase depletion and regeneration in human peripheral lymphocytes following dadarbazine and fotemustine. Cancer Res 1991;51:619-623.
53. 6-alkylguanine-DNA-alkyltransferase in vivo by pretreatment with antineoplastic agents. Biochem Pharmacol 1989;38:929-934.
54. 6-alkylguanine-DNA-alkyltransferase in human peripheral blood mononuclear cells by temozolomide. Br J Cancer 1994;69:452-456.
55. 6-methylguanine-DNA-methyltransferase activity in cerebral gliomas - A guidance for nitrosourea treatment? Acta Oncol 1994;33:29-32.
56. 6-methylguamne-DNA-methyltransferase activity in brain tumors and adjacent normal brain. Cancer Res 1993;53:3416-3420.
57. 6-methylguanine-DNA-methyltransferase activity and clinical responsiveness to ACNU in human brain tumors. Fudushima Med J 1994;44:175-185.
58. Rey JA, Bello MJ, de Compos JM, Kusak ME, Moreno S: Chromosomal composition of a series of 22 human low grade gliomas. Cancer Genet Cytogenet 1987;29:223-237.
59. Stratton MR, Darling JL, Lantos PL, Cooper CS, Reeves BR: Cytogenetic abnormalities in human ependymomas. Int J Cancer 1989;44:579-581.
60. Bown NP, Pearson AD, Davison EV, Bardner-Medwin D, Crawford P, Perry R: Multiple chromosome rearrangements in a childhood ependymoma. Cancer Genet Cytogenet 1988;36:25-30.
61. Dal Cin P, Sandberg AA: Cytogenetic findings in a supratentorial ependymoma. Cancer Genet Cytogenet 1988;30:289-293.
62. Griffin CA, Hawkins AL, Packer RJ, Rorke LB, Emanuel BE: Chromosome abnormalities in pediatric brain tumors. Cancer Res 1988;48:175-180.
63. Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea RL: DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med 1992;326:988-993.